An injection-grade medical solution effective for treating secondary carnitine deficiency symptoms in chronic renal failure patients undergoing long-term hemodialysis. Key Features & Benefits: Mitigates conditions like cardiomyopathy, arrhythmia, muscle spasms during dialysis and more; Administered intravenously after being dissolved in water. Dosage Information: 10-20mg/kg post each hemodialysis session. Storage Strength: Lyophilized powder of 0.5 g.
This product is primarily distributed in regions such as North America, Western Europe, Eastern Asia, the Middle East, and Africa. Please note samples are not provided, and lead delivery time is approximately 2 months.
Levocarnitine is a medicine used to treat and manage several conditions due to secondary carnitine deficiency. It is widely indicated for chronic renal failure patients who undergo long-term hemodialysis. Levocarnitine plays a significant role in fat metabolism; thus, a lack of this substance can lead to metabolic disorders.
Levocarnitine for injection comes as lyophilized powder with a strength of 0.5g. The injection-grade product carries the potential to alter the lives of patients dealing with prolonged carnitine deficiency, providing substantial health rejuvenation.
With main sales markets across North America, Western Europe, Eastern Europe, Asia, the Middle East, and Africa, Levocarnitine for Injection holds a global presence, and it aims to revamp the global health scenario by addressing carnitine deficiencies effectively.
This product does not come with a sample but it guarantees improved health conditions.